Cutaneous laser therapy.

J A Dixon; J J Gilbertson

Home/Archive/PubMed

PubMed · 4090490

Cutaneous laser therapy.

J A Dixon·J J Gilbertson

View original source ↗Export metadata ↓

Abstract

The carbon dioxide laser is useful for vaporizing lesions and applying incisions, the argon laser coagulates superficial vascular lesions and the neodymium-YAG laser is used for large vascular and more deeply situated lesions. Many patients with port-wine stains have been treated with excellent to poor results, major problems consisting of incomplete color removal and hypertrophic scarring (occurring in 4% to 23% of cases). While results are imperfect, patients are satisfied with the improvement in 86% of cases. Lasers have been used with good results for treating patients with strawberry angioma of infancy, pyogenic granuloma, telangiectasia of the face, decorative tattoos, genital condylomata and warts. The results of laser treatment of essential telangiectasia of the lower extremities have generally been poor. The CO(2) laser has been effective in excising small lesions and elevating skin flaps.

Explore related subjects

Condylomata Acuminata Facial Dermatoses Forecasting Hemangioma Humans Laser Therapy Pigmentation Disorders Skin Diseases Skin Neoplasms Tattooing Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J A Dixon, J J Gilbertson. 1985. Cutaneous laser therapy.. https://pubmed.ncbi.nlm.nih.gov/4090490/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Comment on "Human papillomavirus in the oral mucosa of women with genital human papillomavirus lesions" [Eur. J. Obstet. Gynecol. Reprod. Biol. 126 (2006) 104-106].

Explore the source record for details and available documents.

Condylomata Acuminata↗

PubMed2006

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

Human Papillomavirus (HPV)-6 and -11 are the causative agents of ano-genital warts (GWs) and recurrent respiratory papillomatosis (RRP). They are low-risk HPV types that are uncommonly found in malignant lesions. GWs are an extremely prevalent sexually transmitted disease, whereas RRP is a rare disease that can be life threatening and requires multiple surgical procedures. GWs and RRP cause substantial healthcare costs. A quadrivalent HPV-6/11/16/18 vaccine (Merck/SPMSD) has shown essentially 100% protection against GWs in women in early studies. Cost-effectiveness analyses are needed to assess the benefits of the HPV-6/11 virus-like particle (VLP) components of the quadrivalent vaccine in population-based vaccination programmes.

Condylomata Acuminata↗

PubMed2006

An evidence-based review of medical and surgical treatments of genital warts.

Genital human papillomavirus (HPV) infection is the most common sexually transmitted disease. Each year 1 million new cases of genital warts are diagnosed, two thirds of which are in women. The estimated prevalence rate in the US population is 15 percent. HPV infects keratinocytes. Such infection can manifest clinically as warts. Treatment options for genital warts are numerous, well established, and effective. Topical treatments include podophyllin resin, imiquimod, trichloroacetic acid, and podophyllotoxin. Surgical or destructive therapies include carbon dioxide laser, surgical excision, loop excision, cryotherapy, and electrodessication. Interferon can be injected locally or administered systemically to treat genital warts. Evidence of efficacy in the treatment of genital warts is drawn from randomized blind-controlled trials, prospective studies, and retrospective cohort studies. Evidence of efficacy appears to be good, but more head-to-head studies and comparisons of combination therapies versus monotherapy need to be done. Treatment of choice depends on the number, size, and location of lesions. There is little certainty that any approach is more effective than another, however costs differ. It would seem that the first line destructive treatment is cryotherapy, but surgery and electrodesiccation are more effective. The first line topical treatments appear to be podophyllotoxin and imiquimod. Interferon is too expensive and trichloracetic acid is too inconsistent to be recommended as primary treatment. It is unclear if combinations of therapies are more effective than monotherapy. Side effect profile, cost, effectiveness and convenience (ability to attend physician's office or to undertake protracted home treatment) define the choice of therapy.

Condylomata Acuminata↗